Given that it is in early stages of development and the lack of clinical data, 5-amino-1MQ's safety and efficacy remain to be thoroughly investigated through comprehensive clinical trials
ATGL, HSL, MGL, lipid-droplet proteins, coactivators, inhibitory proteins, intracellular localization, and substrate accessibility all influence the measured rate of lipid mobilization
One report of severe chest tightness in the 50 mcg/kg IV arm was deemed possibly related
But, adverse effects are recorded in a way that necessitates their inclusion as B12 injection symptoms
The UK Expert Group on Vitamins and Minerals (EVM) and the European Food Safety Authority (EFSA) have not established a formal upper tolerable intake level for B12 due to its low potential for harm
Some medical conditions or medications can make it less effective or potentially unsafe